Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 5062

1.

Liposomal adjuvants for human vaccines.

Alving CR, Beck Z, Matyas GR, Rao M.

Expert Opin Drug Deliv. 2016 Feb 11. [Epub ahead of print]

PMID:
26866300
2.

Self-assembling protein nanoparticles in the design of vaccines.

López-Sagaseta J, Malito E, Rappuoli R, Bottomley MJ.

Comput Struct Biotechnol J. 2015 Nov 26;14:58-68. doi: 10.1016/j.csbj.2015.11.001. eCollection 2016. Review.

PMID:
26862374
4.

Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria.

Addai-Mensah O, Seidel M, Amidu N, Maskus DJ, Kapelski S, Breuer G, Franken C, Owusu-Dabo E, Frempong M, Rakotozandrindrainy R, Schinkel H, Reimann A, Klockenbring T, Barth S, Fischer R, Fendel R.

Malar J. 2016 Feb 5;15(1):65. doi: 10.1186/s12936-016-1112-1.

5.

Preventing Infections in Sickle Cell Disease: The Unfinished Business.

Obaro SK, Iroh Tam PY.

Pediatr Blood Cancer. 2016 Feb 3. doi: 10.1002/pbc.25911. [Epub ahead of print] Review.

PMID:
26840500
6.

Expanding the antimalarial toolkit: Targeting host-parasite interactions.

Langhorne J, Duffy PE.

J Exp Med. 2016 Feb 8;213(2):143-53. doi: 10.1084/jem.20151677. Epub 2016 Feb 1. Review.

PMID:
26834158
7.

Analysis of the immune response of a new malaria vaccine based on the modification of cryptic epitopes.

Shen Y, Wang J, Huang Y, Liang J, Liu X, Wu D, Jiang H, Zhao Y, Li Y.

Parasitol Res. 2016 Jan 30. [Epub ahead of print]

PMID:
26833322
8.

Merozoite surface proteins in red blood cell invasion, immunity and vaccines against malaria.

Beeson JG, Drew DR, Boyle MJ, Feng G, Fowkes FJ, Richards JS.

FEMS Microbiol Rev. 2016 Jan 31. pii: fuw001. [Epub ahead of print] Review.

PMID:
26833236
9.

Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria.

Ganeshan H, Kusi KA, Anum D, Hollingdale MR, Peters B, Kim Y, Tetteh JK, Ofori MF, Gyan BA, Koram KA, Huang J, Belmonte M, Banania JG, Dodoo D, Villasante E, Sedegah M.

Malar J. 2016 Feb 1;15(1):55. doi: 10.1186/s12936-016-1098-8.

10.

Malaria vaccine: WHO position paper-January 2016.

[No authors listed]

Wkly Epidemiol Rec. 2016 Jan 4;91(4):33-51. English, French. No abstract available.

PMID:
26829826
11.

Global Advisory Committee on Vaccine Safety, 2-3 December 2015.

[No authors listed]

Wkly Epidemiol Rec. 2016 Jan 22;91(3):21-31. English, French. No abstract available.

PMID:
26829825
12.

Management of septic shock and severe infections in migrants and returning travelers requiring critical care.

Alp E, Erdem H, Rello J.

Eur J Clin Microbiol Infect Dis. 2016 Jan 29. [Epub ahead of print]

PMID:
26825315
13.

Sickle cell disease.

Meremikwu MM, Okomo U.

BMJ Clin Evid. 2016 Jan 22;2016. pii: 2402.

PMID:
26808098
14.

Malawi and Millennium Development Goal 4: a Countdown to 2015 country case study.

Kanyuka M, Ndawala J, Mleme T, Chisesa L, Makwemba M, Amouzou A, Borghi J, Daire J, Ferrabee R, Hazel E, Heidkamp R, Hill K, Álvarez MM, Mgalula L, Munthali S, Nambiar B, Nsona H, Park L, Walker N, Daelmans B, Bryce J, Colbourn T.

Lancet Glob Health. 2016 Jan 21. pii: S2214-109X(15)00294-6. doi: 10.1016/S2214-109X(15)00294-6. [Epub ahead of print]

15.

In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.

Rodrigues-da-Silva RN, Martins da Silva JH, Singh B, Jiang J, Meyer EV, Santos F, Banic DM, Moreno A, Galinski MR, Oliveira-Ferreira J, Lima-Junior Jda C.

PLoS One. 2016 Jan 20;11(1):e0146951. doi: 10.1371/journal.pone.0146951. eCollection 2016.

16.

Severe Plasmodium falciparum malaria: targets and mechanisms associated with protection in Kenyan children.

Murungi LM, Sondén K, Llewellyn D, Rono J, Guleid F, Williams AR, Ogada E, Thairu A, Färnert A, Marsh K, Draper SJ, Osier FH.

Infect Immun. 2016 Jan 19. pii: IAI.01120-15. [Epub ahead of print]

17.

Application of a Scalable Plant Transient Gene Expression Platform for Malaria Vaccine Development.

Spiegel H, Boes A, Voepel N, Beiss V, Edgue G, Rademacher T, Sack M, Schillberg S, Reimann A, Fischer R.

Front Plant Sci. 2015 Dec 23;6:1169. doi: 10.3389/fpls.2015.01169. eCollection 2015.

18.

Progress and prospects for blood-stage malaria vaccines.

Miura K.

Expert Rev Vaccines. 2016 Feb 3:1-17. [Epub ahead of print]

PMID:
26760062
19.

Plasmodium malaria and antimalarial antibodies in the first year of life.

Dobbs KR, Dent AE.

Parasitology. 2016 Feb;143(2):129-38. doi: 10.1017/S0031182015001626. Epub 2016 Jan 8.

PMID:
26743626
20.

Enhancing immunogenicity and transmission-blocking activity of malaria vaccines by fusing Pfs25 to IMX313 multimerization technology.

Li Y, Leneghan DB, Miura K, Nikolaeva D, Brian IJ, Dicks MD, Fyfe AJ, Zakutansky SE, de Cassan S, Long CA, Draper SJ, Hill AV, Hill F, Biswas S.

Sci Rep. 2016 Jan 8;6:18848. doi: 10.1038/srep18848.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk